Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Development of an Oral Drug Delivery System Targeting Immune-Regulating Cells in Experimental Inflammatory Bowel Disease: A New Therapeutic Strategy
Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Suguru Uose, Masaya Ohana, Kazushige Uchida, Yumi Matsushima, Chiharu Kawanami, Chikashi Oshima, Yoshito Ikada and Tsutomu Chiba
Journal of Pharmacology and Experimental Therapeutics January 2000, 292 (1) 15-21;
Hiroshi Nakase
Kazuichi Okazaki
Yasuhiko Tabata
Suguru Uose
Masaya Ohana
Kazushige Uchida
Yumi Matsushima
Chiharu Kawanami
Chikashi Oshima
Yoshito Ikada
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 292, Issue 1
1 Jan 2000
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Development of an Oral Drug Delivery System Targeting Immune-Regulating Cells in Experimental Inflammatory Bowel Disease: A New Therapeutic Strategy
Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Suguru Uose, Masaya Ohana, Kazushige Uchida, Yumi Matsushima, Chiharu Kawanami, Chikashi Oshima, Yoshito Ikada and Tsutomu Chiba
Journal of Pharmacology and Experimental Therapeutics January 1, 2000, 292 (1) 15-21;
Research ArticleINFLAMMATION AND IMMUNOPHARMACOLOGY
Development of an Oral Drug Delivery System Targeting Immune-Regulating Cells in Experimental Inflammatory Bowel Disease: A New Therapeutic Strategy
Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Suguru Uose, Masaya Ohana, Kazushige Uchida, Yumi Matsushima, Chiharu Kawanami, Chikashi Oshima, Yoshito Ikada and Tsutomu Chiba
Journal of Pharmacology and Experimental Therapeutics January 1, 2000, 292 (1) 15-21;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement